Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;45(2):140-146.
doi: 10.1080/13816810.2024.2303682. Epub 2024 Jan 30.

A proposal for an updated staging system for LCHADD retinopathy

Affiliations

A proposal for an updated staging system for LCHADD retinopathy

Nida Wongchaisuwat et al. Ophthalmic Genet. 2024 Apr.

Abstract

Objective: To develop an updated staging system for long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency (LCHADD) chorioretinopathy based on contemporary multimodal imaging and electrophysiology.

Methods: We evaluated forty cases of patients with genetically confirmed LCHADD or trifunctional protein deficiency (TFPD) enrolled in a prospective natural history study. Wide-field fundus photographs, fundus autofluorescence (FAF), optical coherence tomography (OCT), and full-field electroretinogram (ffERG) were reviewed and graded for severity.

Results: Two independent experts first graded fundus photos and electrophysiology to classify the stage of chorioretinopathy based upon an existing published system. With newer imaging modalities and improved electrophysiology, many patients did not fit cleanly into a single traditional staging group. Therefore, we developed a novel staging system that better delineated the progression of LCHADD retinopathy. We maintained the four previous delineated stages but created substages A and B in stages 2 to 3 to achieve better differentiation.

Discussion: Previous staging systems of LCHADD chorioretinopathy relied on only on the assessment of standard 30 to 45-degree fundus photographs, visual acuity, fluorescein angiography (FA), and ffERG. Advances in recordings of ffERG and multimodal imaging with wider fields of view, allow better assessment of retinal changes. Following these advanced assessments, seven patients did not fit neatly into the original classification system and were therefore recategorized under the new proposed system.

Conclusion: The new proposed staging system improves the classification of LCHADD chorioretinopathy, with the potential to lead to a deeper understanding of the disease's progression and serve as a more reliable reference point for future therapeutic research.

Keywords: LCHAD deficiency; LCHADD; chorioretinopathy; staging.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
First row; fundus images representing from stage 1 to 4. Second row representing fundus autofluorescence start from speckle hypoautofluorescence mostly within vascular arcades in stage 2A progressing to nearly total dense hypoautofluorescence towards periphery in stage 4 (red arrow) third row demonstrates cross-sectional OCT scan of central macular area comparing each stages, severe attenuation of choroid was observed by OCT in stage 3B.(yellow arrow) fourth and fifth rows showing scotopic ERG and photopic ERG response respectively, amplitude of b wave gradually decline in more advance stages.

References

    1. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol. 2002;64(1):477–502. doi:10.1146/annurev.physiol.64.082201.154705. - DOI - PubMed
    1. Xia C, Fu Z, Battaile KP, Kim JP. Crystal structure of human mitochondrial trifunctional protein, a fatty acid β-oxidation metabolon. Proc Natl Acad Sci USA. 2019;116(13):6069–74. doi:10.1073/pnas.1816317116. - DOI - PMC - PubMed
    1. Liang K, Li N, Wang X, Dai J, Liu P, Wang C, Chen XW, Gao N, Xiao J. Cryo-EM structure of human mitochondrial trifunctional protein. Proc Natl Acad Sci USA. 2018;115(27):7039–7044. doi:10.1073/pnas.1801252115. - DOI - PMC - PubMed
    1. Fletcher AL, Pennesi ME, Harding CO, Weleber RG, Gillingham MB. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2012;106 (1):18–24. doi:10.1016/j.ymgme.2012.02.015. - DOI - PMC - PubMed
    1. Boutron A, Acquaviva C, Vianey-Saban C, de Lonlay P, de Baulny HO, Guffon N, Dobbelaere D, Feillet F, Labarthe F, Lamireau D, et al. Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab. 2011;103(4):341–348. doi:10.1016/j.ymgme.2011.04.006. - DOI - PubMed

Substances

Supplementary concepts